Ronald Bailey on How to Save Lives by Getting the FDA into the 21st Century

"FDA is relying on 20th century regulatory science to evaluate 21st century medical products," declared Food and Drug Administration Commissioner Margaret Hamburg back in October 2010. One result: As biotech and medical discoveries accelerate the number of new drugs approved by the agency remains basically flat. Reason Science Correspondent Ronald Bailey thinks that a new Manhattan Institute study arguing for the conditional approval of new drugs as a way to speed access to patients is on the right track.